Literature DB >> 7970706

Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer.

P Rimessi1, F Gualandi, C Morelli, C Trabanelli, Q Wu, L Possati, M Montesi, J C Barrett, G Barbanti-Brodano.   

Abstract

The molecular pathogenesis of ovarian carcinoma involves altered expression of growth factors, activation of oncogenes and loss of tumor suppressor genes. Loss of heterozygosity on chromosomes 3p, 6q, 11p, 17 and 18q was reported as a significant alteration in ovarian cancer. However, no functional proof has been provided of tumor suppressor activity located in these chromosomal regions. We therefore introduced normal human chromosomes 3 and 11 into an ovarian carcinoma cell line by microcell mediated chromosome transfer. Transfer of chromosome 3 induced senescence and growth arrest as well as suppression of tumorigenicity. Tumors induced by chromosome 3 monochromosomic hybrids consistently lost three small regions on 3p, two of which located in 3p23-24.2 and one located in 3p21.1-21.2, suggesting that these chromosomal regions are important for suppression of tumorigenicity of ovarian carcinoma cells. Transfer of chromosome 11 reduced the in vitro growth properties of ovarian cancer cells but did not significantly affect tumorigenicity. These results provide functional evidence for chromosome 3 tumor suppressor activity in ovarian cancer and define the chromosomal regions on 3p involved in the pathogenesis of this tumor. This experimental system, based on functional effects, may be useful for further delimitation and isolation of critical regions on 3p involved in tumor suppression.

Entities:  

Mesh:

Year:  1994        PMID: 7970706

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.

Authors:  Emily N Manderson; Anne-Marie Mes-Masson; Jaroslav Novak; Peter D Lee; Diane Provencher; Thomas J Hudson; Patricia N Tonin
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

Review 2.  Molecular genetics of ovarian cancer.

Authors:  A N Shelling; W Foulkes
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

3.  Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.

Authors:  Joseph Kwong; Ji-Young Lee; Kwong-Kwok Wong; Xiaofeng Zhou; David T W Wong; Kwok-Wai Lo; William R Welch; Ross S Berkowitz; Samuel C Mok
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

4.  Characterization of the human beta-catenin gene.

Authors:  A L Norris; A Bailey; J Askham; A Whitehouse; P M Clissold; A F Markham; D M Meredith
Journal:  Mamm Genome       Date:  1996-02       Impact factor: 2.957

5.  A mortality gene(s) for the human adenocarcinoma line HeLa maps to a 130-kb region of human chromosome 4q22-q23.

Authors:  Steven D Bryce; Vivienne Morrison; Nicola J Craig; Nicholas R Forsyth; Sara A Fitzsimmons; Hazel Ireland; Andrew P Cuthbert; Robert F Newbold; E Kenneth Parkinson
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

6.  Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data.

Authors:  Iuliana Ionita; Raoul-Sam Daruwala; Bud Mishra
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025

Review 7.  The manipulation of chromosomes by mankind: the uses of microcell-mediated chromosome transfer.

Authors:  Karen J Meaburn; Christopher N Parris; Joanna M Bridger
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

8.  Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.

Authors:  Yoon-La Choi; So Young Kang; Young Kee Shin; Jong Sun Choi; Seok Hyung Kim; Sun-Joo Lee; Duk-Soo Bae; Geunghwan Ahn
Journal:  Virchows Arch       Date:  2005-11-29       Impact factor: 4.064

9.  Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics.

Authors:  Bei H Morrison; Joseph A Bauer; Jiadi Hu; Ronald W Grane; Aylin M Ozdemir; Mamta Chawla-Sarkar; Bendi Gong; Alex Almasan; Dhananjaya V Kalvakolanu; Daniel J Lindner
Journal:  Oncogene       Date:  2002-03-14       Impact factor: 9.867

10.  Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.

Authors:  A Martinez; R A Walker; J A Shaw; S J Dearing; E R Maher; F Latif
Journal:  Mol Pathol       Date:  2001-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.